|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 9/28 | |
| A61K 9/16 | |||
| A61K 9/20 |
| (11) | Patento numeris | 1663170 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04710656.2 |
| Europos patento paraiškos padavimo data | 2004-02-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-06-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-06-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2004/004112 |
| Data | 2004-02-12 |
| (87) | Numeris | WO 2005/039540 |
| Data | 2005-05-06 |
| (30) | Numeris | Data | Šalis |
| 664803 | 2003-09-19 | US |
| (72) |
LODIN, Unchalee, US
GOLDFARB, Robert, I., US
CARDINAL, John, US
NANGIA, Avinash, US
|
| (73) |
Andrx Labs LLC,
4955 Orange Drive, Davie, FL 33314,
US
|
| (54) | NOVEL PHARMACEUTICAL FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE |
| NOVEL PHARMACEUTICAL FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE |